Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ABIVAX Société Anonyme (PA: ABVX)

 
ABVX Technical Analysis
5
As on 17th Sep 2025 ABVX STOCK Price closed @ 69.40 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 9.94 & Strong Buy for SHORT-TERM with Stoploss of 13.25 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ABVXSTOCK Price

Open 69.70 Change Price %
High 71.10 1 Day 0.80 1.17
Low 68.70 1 Week -5.90 -7.84
Close 69.40 1 Month 8.10 13.21
Volume 58586 1 Year 55.42 396.42
52 Week High 76.50 | 52 Week Low 4.56
 
PA France Most Active Stocks
ALVER 0.00 %
ALEUP 0.00 %
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
LAT 0.01 %
CGG 0.69 -2.82%
ALHYG 0.01 0.00%
ALNRG 0.00 %
ALTBG 2.88 %
VLA 4.20 11.11%
 
PA France Top Gainers Stocks
GNRO 0.05 66.67%
ALMUN 0.76 11.76%
VLA 4.20 11.11%
VLA 4.20 11.11%
ALUCI 0.10 11.11%
ALSTW 73.00 10.61%
MLOCT 0.22 10.00%
MLSRP 40.40 9.78%
MLWEA 1.62 9.46%
2MX 7.46 8.43%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
MLPRX 0.19 -13.64%
ALIMP 0.28 -12.50%
ALNEV 0.28 -12.50%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
ALSGD 0.08 -11.11%
ALTHX 2.24 -9.31%
 
 
ABVX
Daily Charts		 ABVX
Intraday Charts		 Whats New @
Bazaartrend		 ABVX
Free Analysis
 
ABVX Important Levels Intraday
RESISTANCE74.02
RESISTANCE72.54
RESISTANCE71.62
RESISTANCE70.71
SUPPORT68.09
SUPPORT67.18
SUPPORT66.26
SUPPORT64.78
 
ABVX Forecast September 2025
Share
4th UP Forecast73.52
3rd UP Forecast72.2
2nd UP Forecast71.38
1st UP Forecast70.57
1st DOWN Forecast68.23
2nd DOWN Forecast67.42
3rd DOWN Forecast66.6
4th DOWN Forecast65.28
 
ABVX Weekly Forecast
4th UP Forecast72.17
3rd UP Forecast71.28
2nd UP Forecast70.73
1st UP Forecast70.18
1st DOWN Forecast68.62
2nd DOWN Forecast68.07
3rd DOWN Forecast67.52
4th DOWN Forecast66.63
 
ABVX Forecast2025
4th UP Forecast212.36
3rd UP Forecast166.51
2nd UP Forecast138.17
1st UP Forecast109.83
1st DOWN Forecast28.97
2nd DOWN Forecast0.63
3rd DOWN Forecast-27.71
4th DOWN Forecast-73.56
 
 
ABVX Other Details
Segment EQ
Market Capital 494349600.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ABVX Address
ABVX
 
ABVX Latest News
 
Your Comments and Response on ABIVAX Société Anonyme
 
ABVX Business Profile
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France. Address: 5, rue de la Baume, Paris, France, 75008
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service